Neurovascular devices are used for the treatment and management of neurovascular disorders such as cerebral aneurysm and stenosis. The global neurovascular devices market was valued at $2,371 million in 2016, and is estimated to reach $3,409 million by 2023, growing at a CAGR of 5.3% during the study period. This is attributed to increase in geriatric population and upsurge in number of patients suffering from neurovascular disorders. Moreover, rise in adoption of new minimally invasive techniques such as flow diversion and carotid artery stenting boosts the market growth. However, high cost of the devices and dearth of neurosurgeons are expected to impede the market growth.
The global neurovascular devices market is segmented on the basis of product, disease pathology, and geography. Based on product, the market is classified into embolization devices, revascularization devices, accessory devices, thrombectomy devices, and emboli protection devices. By disease pathology, it is divided into aneurysm, arteriovenous malformation & fistulas (AVM), ischemic stroke, and stenosis. Geographically, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The global neurovascular devices market is highly competitive and is lucrative in nature. The key market players have adopted various developmental strategies such as product launch & approval, strategic acquisitions, and mergers to strengthen their market position.
KEY BENEFITS FOR STAKEHOLDERS
This report provides an extensive analysis of the current & emerging market trends and dynamics in the global neurovascular devices market.
Comprehensive analysis of geographical regions is provided to determine the prevailing opportunities in the global market.
This study provides the competitive landscape of the global market to predict the competitive environment globally.
This report entails the detailed quantitative analysis of the current trends and future estimations from 2016 to 2023 to identify the prevailing opportunities.
Comprehensive analysis of factors that drive and restrain the market growth is provided in the report.
KEY MARKET SEGMENTS
By Product
Embolization Devices
Clippings
Embolic Coils
Bare Detachable Coils
Coated Detachable Coils
Coil Assist Stent
Revascularization Devices
Carotid Artery Stents
Flow Diversion Stents
Accessory Devices
Microcatheters
Microguidewires
Thrombectomy Devices
Clot Retrieval Devices
Suction & Aspiration Devices
Snares
Embolic Protection Devices
Distal Filter Devices
Balloon Occlusion Devices
By Disease Pathology
Aneurysm
Arteriovenous Malformation and Fistulas (AVM)
Ischemic Stroke
Stenosis
By Region
North America
U.S.
Canada
Mexico
Europe
France
Germany
UK
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
India
Australia
South Korea
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA
The key players in the global neurovascular devices market include:
Stryker Corporation
Medtronic Plc.
Johnson & Johnson
Integer Holdings Corporation
Terumo Corporation
Penumbra, Inc.
Boston Scientific Corporation
Microport Scientific Corporation
Merit Medical Systems, Inc.
W.L. Gore & Associates
Acandis GmbH & Co. KG
